Thomas Kieber-Emmons
Significant improvements may result from the selection of the appropriate tumor-specific target antigen (to overcome the peripheral immune tolerance) and/or the development of immunization strategies effective at inducing a protective immune response. This review aims to describe the vast spectrum of tumor antigens and strategies to develop cancer vaccines. We have previously studied the generation of immune responses after vaccination with tumor-associated carbohydrate
